key: cord-1003221-33cmymur authors: Radtke, T.; Ulyte, A.; Puhan, M. A.; Kriemler, S. title: Long-term symptoms after SARS-CoV-2 infection in school children: population-based cohort with 6-months follow-up. Short Report date: 2021-05-18 journal: nan DOI: 10.1101/2021.05.16.21257255 sha: f72677c976a863d1d4fb40b6afe4fbd87701e5b6 doc_id: 1003221 cord_uid: 33cmymur Although nobody doubts the existence of long COVID in children, it is still unclear to what extent children are affected. The Ciao Corona study is a longitudinal cohort investigating SARS-CoV-2 seroprevalence and clustering of cases among around 2500 children from 55 randomly selected primary and secondary schools in the canton of Zurich in Switzerland. Between June 2020 and April 2021, we completed three testing phases where we collected venous blood for serological analysis (ABCORA 2.0 test) and asked about symptoms with online questionnaires. We compared children who tested positive for SARS-CoV-2 antibodies in October/November 2020 with those who tested negative. Children who were seronegative in October/November 2020 and seroconverted or were not retested by March/April 2021 were excluded from the analysis (n=256). In March-May 2021 we assessed the presence of symptoms occurring since October 2020, lasting for at least 4 weeks, and persisting for either >4 weeks or >12 weeks. Overall, 1355 of 2503 children with a serology result in October/November 2020 and follow up questionnaire in March/April 2021 were included. Among seropositive and seronegative 6- to 16-year-old children and adolescents, 9% versus 10% reported at least one symptom beyond 4 weeks, and 4% versus 2% at least one symptom beyond 12 weeks. None of the seropositive children reported hospitalization after October 2020. This study suggests a very low prevalence of long COVID in a randomly selected population-based cohort of children followed over 6 months after serological testing. Importantly, seropositive children, all with a history of pauci-symptomatic SARS-CoV-2 infection, did not report long COVID more frequently than seronegative children. Children can suffer from SARS-CoV-2 postviral syndromes, but it is yet unclear to what extent children are affected by long COVID (i.e., symptoms that continue for more than 12 weeks and are not explained by an alternative diagnosis). 1 Current evidence is predominantly . CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted May 18, 2021. ; https://doi.org/10.1101/2021.05.16.21257255 doi: medRxiv preprint limited to selective -mostly clinical -populations without control groups [2] [3] [4] [5] , which do not allow estimating the overall prevalence and burden in a general pediatric population. In this study, we compared long COVID related symptoms in children and adolescents (hereafter referred to as children) with 6-months follow-up according to their SARS-CoV-2 serology. The Ciao Corona study is a longitudinal cohort investigating SARS-CoV-2 seroprevalence and clustering of cases among around 2500 children from 55 randomly selected primary and secondary schools in the canton of Zurich (about 1.5 million inhabitants) in Switzerland (study design described elsewhere 6 ). Between June 2020 and April 2021, we completed three testing phases where we collected venous blood for serological analysis and asked about symptoms with online questionnaires. For serological analysis, we used the ABCORA 2.0 test. 6 In this analysis, we compared children who tested positive for SARS-CoV-2 antibodies in October/November 2020 with those who tested negative. Children who were seronegative in October/November 2020 and seroconverted or were not retested by March/April 2021 were excluded from the analysis (n=256). In March-May 2021 we assessed the presence of symptoms occurring since October 2020 and lasting for at least 4 weeks 3 , and persisting for either >4 weeks or >12 weeks. Descriptive analysis was performed with R version 4.0.3. The Ethics Committee of the Canton of Zurich, Switzerland (2020-01336) approved the study and parents/legal guardians provided written informed consent. . CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted May 18, 2021. ; https://doi.org/10.1101/2021.05.16.21257255 doi: medRxiv preprint Overall, 1355 of 2503 children with a serology result in October/November 2020 and follow up questionnaire in March/April 2021 were included. Participant characteristics, symptoms and self-rated health are summarized in the Table. Among seropositive and seronegative children, 9% versus 10% reported at least one symptom beyond 4 weeks, and 4% versus 2% at least one symptom beyond 12 weeks (Table) . None of the seropositive children reported hospitalization after October 2020. The distribution of pre-existing chronic diseases among seropositive (n=109) and seronegative children (n=1246) is given in Supplemental Table S1 . Participant characteristics, symptoms and self-rated health for a subpopulation of seropositive (n=89) and seronegative children (n=891) without chronic disease is shown in Table S2 . . CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) (2) 2 (0) *Among seropositive and seronegative children, 3 (3%) and 22 (2%) reported ongoing symptoms. The item self-rated health from the Health Behaviour in School-Aged Children (HBSC) -Survey Instrument Would you say your health is…? assesses perceived health status of a child/adolescent and includes four response categories labelled as "excellent", "good", "fair", "poor". Self-rated health was not reported for 3 seropositive and 19 seronegative children. # 6/1246 (0.482%). . CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted May 18, 2021. This study suggests a very low prevalence of long COVID in a randomly selected populationbased cohort of children followed over 6 months after serological testing. Seropositive children, all with a history of pauci-symptomatic SARS-CoV-2 infection, did not report long COVID more frequently than seronegative children. is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted May 18, 2021. ; https://doi.org/10.1101/2021.05.16.21257255 doi: medRxiv preprint 7 stated by SSPH+ were respected), by funds of the cantons of Switzerland (Vaud, Zurich, and Basel), and by institutional funds of the universities. Additional funding, specific to this study, was available from the University of Zurich Foundation. The funder/sponsor did not have any role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication. All authors had full access to all data analysis outputs (reports and tables) and take responsibility for their integrity and accuracy. None . CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted May 18, 2021. ; https://doi.org/10.1101/2021.05.16.21257255 doi: medRxiv preprint COVID-19 rapid guideline: managing the long-term effects of COVID-19 | Guidance | NICE Illness duration and symptom profile in a large cohort of symptomatic UK school-aged children tested for SARS-CoV-2. medRxiv Clinical Characteristics, Activity Levels and Mental Health Problems in Children with Long COVID: A Survey of 510 Children Preliminary evidence on long COVID in children Post-acute COVID-19 outcomes in children with mild and asymptomatic disease. The Lancet Child & Adolescent Health Clustering and longitudinal change in SARS-CoV 2 seroprevalence in school children in the canton of Zurich, Switzerland: prospective cohort study of 55 schools. BMJ. 2021;372:n616. doi:10.1136/bmj.n616 . CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted May 18, 2021. ; https://doi.org/10.1101/2021.05.16.21257255 doi: medRxiv preprint 9 . CC-BY-NC 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted May 18, 2021. ; https://doi.org/10.1101/2021.05.16.21257255 doi: medRxiv preprint